Home > Analytics > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 539730     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : NA
Jun 07,2023
Price(EOD): β‚Ή 841.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 387.14 Cr
Value of β‚Ή 1 Lac invested in FREDUN PHARMACEUTICALS
on Jun 07,2018 (price: β‚Ή 292.80)

β‚Ή 1 L

β‚Ή 2.87 L

1W : -0.9% 1M : -14.5% 1Y : -7.9%
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
FREDUN PHARMACEUTICALS -0.9% -14.5% -7.9%
SUN PHARMACEUTICAL INDUSTRIES 2.7% 5.9% 17.9%
DIVIS LABORATORIES 0.5% 4.8% 0.3%
CIPLA -0.4% 2.3% -1.5%
DR REDDYS LABORATORIES 2.6% -5.3% 7%
TORRENT PHARMACEUTICALS 1.5% 9.3% 27.1%
ABBOTT INDIA 1.3% -0.2% 18.8%
ZYDUS LIFESCIENCES 0.3% -1.9% 41.3%
ALKEM LABORATORIES 0.8% -5.8% 9.5%

FUNDAMENTAL ANALYSIS OF FREDUN PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Dec2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF FREDUN PHARMACEUTICALS

 
Valuation Score
[As on : Jun 07,2023 ]

Ratio Standalone
P/E
P/B
P/S
39.14
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 9.85 Cr
[Latest Qtr - Dec2022 - Standalone Results ]

5.68
P/B Calculated based on Book Value of Rs 67.85 Cr
[Latest Year - Mar2022 - Standalone Results ]

1.44
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2022 - Standalone Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 23% undervalued companies ! Discover More →

FAIR VALUE OF FREDUN PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
185%
54%
41%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF FREDUN PHARMACEUTICALS


Insights πŸ’‘ There are 48% companies with bullish price momentum currently! Discover More →

FREDUN PHARMACEUTICALS vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF FREDUN PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.78
0.92
0.84
0.85
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF FREDUN PHARMACEUTICALS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF FREDUN PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
10.85%
7.5%
9.61%
9.58%
43.74%
67.76%
80.74%
84.56%
QtrlyTrend
8
Latest Qtr: Dec2022
Quarterly Result Analysis →

Insights πŸ’‘ FREDUN PHARMACEUTICALS is one of the top 43% companies with good quarterly result uptrend ! Discover More →

FREDUN PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about FREDUN PHARMACEUTICALS


Is FREDUN PHARMACEUTICALS good for long term investment?

As on Jun 07,2023, the Fundamentals of FREDUN PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of FREDUN PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is FREDUN PHARMACEUTICALS UnderValued or OverValued?

As on Jun 07,2023, FREDUN PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of FREDUN PHARMACEUTICALS ?

As on Jun 07,2023, the Intrinsic Value of FREDUN PHARMACEUTICALS is Rs. 547.29 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 295.04
Fair Value [Median EV / Sales Model] : Rs. 547.29
Fair Value [Median Price / Sales Model] : Rs. 596.04
Estimated Median Fair Value of FREDUN PHARMACEUTICALS : Rs. 547.29

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is FREDUN PHARMACEUTICALS trading at a Premium or Discount?

As on Jun 07,2023, FREDUN PHARMACEUTICALS is trading at a Premium of 54% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].